EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical application of combination [11C]C-methionine and [13N]N-ammonia PET/CT in recurrent functional pituitary adenomas with negative MRI or [18F]F-FDG PET/CT

Zongming Wang, Zize Feng, Dimin Zhu, Xin Wang, Jinping Chen, Yonghong Zhu, Haijun Wang

BMC Endocrine Disorders · 2024

DOI: 10.1186/s12902-024-01543-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Endocrine Disorders, 2024. Verfasst von Zongming Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Pituitary Tumor Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Adenoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Science and Technology Project, National Natural Science Foundation of China for Young Scholars, Natural Science Foundation of Guangdong Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We assessed the value of positron emission tomography/computed tomography (PET/CT) with [ 13 N]N-ammonia ([ 13 N]N-NH3) and [ 11 C]C-methionine ([ 11 C]C-MET) for the evaluation and management of recurrent secreting pituitary adenoma, which could not be detected by magnetic resonance imaging (MRI) or fluorine-18 fluorodeoxyglucose ([ 18 F]F-FDG) PET.

Methods

Nine consecutive patients with biochemical and clinical evidence of active recurrent tumor not detected by MRI and [ 18 F]F-FDG PET were enrolled in this study. All of the patients underwent [ 13 N]N-NH3 and [ 11 C]C-MET PET/CT, after which the pattern of tracer uptake was studied, the tumor position was located, and a clinical decision was made.

Results

In general, [ 11 C]C-MET had a higher uptake in pituitary adenomas (PAs) than that in pituitary tissues, while [ 13 N]N-NH3 had a higher uptake in pituitary tissue than in pituitary adenomas. Increased [ 11 C]C-MET uptake was observed in all nine PAs and three pituitary tissues, while all pituitary tissues and only one pituitary adenoma showed increased [ 13 N]N-NH3 uptake. Four patients had concordant imaging and surgical findings indicative of biochemical remission without hypopituitarism after treatment. Radiotherapy was adopted in two patients, medication in another two, and follow-up observation in one case.

Conclusion

Combined [ 11 C]C-MET and [ 13 N]N-NH3 PET/CT is effective in the differentiation of PAs from pituitary tissue in recurrent functional PAs with negative MRI or [ 18 F]F-FDG PET. These results provide a valuable reference for further disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary NeoplasmsAdenomaHumansPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18MethionineAmmoniaNeoplasm Recurrence, LocalPositron-Emission TomographyRacemethionineMagnetic Resonance ImagingRadiopharmaceuticals

Stichwörter der Autor:innen

PET/CTPituitary adenoma[11C]C-methionine[13N]N-ammonia

Substanzen

Fluorodeoxyglucose F18MethionineAmmoniaRacemethionineRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Neurosurgery, Pituitary Tumor Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Department of Neurosurgery, Jiangmen Central Hospital, Guangdong, China.
  • Department of Histology and Embryology, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, China.
  • Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China. zhuyongh@mail.sysu.edu.cn.
  • Department of Neurosurgery, Pituitary Tumor Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. wanghaij@mail.sysu.edu.cn.

Förderung

  • Guangzhou Science and Technology Project
  • National Natural Science Foundation of China for Young Scholars
  • Natural Science Foundation of Guangdong Province, China
  • Medical Science and Technology Research Foundation of Guangdong Province, China
  • Sun Yat-sen University Clinical Research 5010 Program

Zitieren

APA

Wang, Z., Feng, Z., Zhu, D., Wang, X., Chen, J., Zhu, Y., & Wang, H. (2024). Clinical application of combination [11C]C-methionine and [13N]N-ammonia PET/CT in recurrent functional pituitary adenomas with negative MRI or [18F]F-FDG PET/CT. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01543-2

Vancouver

Wang Z, Feng Z, Zhu D, Wang X, Chen J, Zhu Y, et al. Clinical application of combination [11C]C-methionine and [13N]N-ammonia PET/CT in recurrent functional pituitary adenomas with negative MRI or [18F]F-FDG PET/CT. BMC Endocrine Disorders. 2024. doi:10.1186/s12902-024-01543-2

BibTeX
@article{Wang2024,
  author = {Wang, Zongming and Feng, Zize and Zhu, Dimin and Wang, Xin and Chen, Jinping and Zhu, Yonghong and Wang, Haijun},
  title = {Clinical application of combination [11C]C-methionine and [13N]N-ammonia PET/CT in recurrent functional pituitary adenomas with negative MRI or [18F]F-FDG PET/CT},
  journal = {BMC Endocrine Disorders},
  year = {2024},
  doi = {10.1186/s12902-024-01543-2}
}
Kostenlos starten →